Peptide V3 Inhibits the Growth of Human Hepatocellular Carcinoma by Inhibiting the Ras/Raf/MEK/ERK Signaling Pathway

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths. Peptide V3 has shown anti-angiogenic and anti-tumor effects on S180 and H22 xenografts in nude mice. However, the detailed mechanism of action of peptide V3 has not yet been fully elucidated. In the present study,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cancer
Auteurs principaux: Wu, Dongdong, Li, Mengling, Gao, Yingran, Tian, Wenke, Li, Jianmei, Zhang, Qianqian, Liu, Zhengguo, Zheng, Mengli, Wang, Hongju, Wang, Jun, Teng, Tieshan, Zhang, Lei, Ji, Xinying, Xie, Zhongwen, Ji, Ailing, Li, Yanzhang
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2019
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548006/
https://ncbi.nlm.nih.gov/pubmed/31205525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.29211
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires